Traws Pharma, Inc. has deferred a planned Phase 2a human influenza challenge study of tivoxavir marboxil, known as TXM, following a negative review of the program by the United Kingd...
Latest Press Releases
-
-
GNI Group to Acquire Ayumi Pharmaceutical in Deal Valued at Approximately ¥44.8 Billion
GNI Group Co., Ltd. has agreed to acquire all shares of Ayumi Pharmaceutical Holdings Co., Ltd. from shareholders led by Blackstone. The transaction values Ayumi at approximately ¥44...
-
Diagnostics Imaging Market Forecasts 5.3% CAGR Through 2032 to USD 54.6 Billion
Overview The Global Diagnostic Imaging Market was valued at USD 33 billion in 2022 and is projected to reach nearly USD 54.6 billion by 2032. A CAGR of 5.3% is expected during 2023–2...
-
Face Mask Machine Market Set for US$ 27.4 Billion Valuation in 2032 at 9.1% CAGR
Overview The Face Mask Machine Market is projected to reach USD 27.4 billion by 2032, increasing from USD 11.7 billion in 2022. The sector is expected to grow at a CAGR of 9.1% from ...
-
Sexually Transmitted Disease Market Set for USD 171 Billion by 2032, CAGR at 6.17%
Overview The Global Sexually Transmitted Disease (STD) Market is projected to reach USD 171 billion by 2032, rising from USD 95 billion in 2022. Growth is expected at a CAGR of 6.17%...
